Company News
-
First Whole-Genome–Based Traceability Analysis of Brucella abortus in Zhejiang Province – Bioinformatics Team from Macro & Micro-Test Contributes to Joint Publication
—— Collaborative Study by Zhejiang CDC, Macro & Micro-Test, and China CDC Published in Frontiers in Cellular and Infection Microbiology Study Overview In May 2026, Frontiers in Cellular and Infection Microbiology (JCR Q1, IF ≈ 4.6) published a paper led by the Zhejiang Provincial Center for D...Read more -
Macro & Micro-Test Launches Comprehensive Syndromic Diagnostic Panels for Rapid and Accurate Infectious Disease Detection
Macro & Micro-Test is proud to introduce its Comprehensive Syndromic Diagnostic Panel Solutions, designed to support rapid, accurate, and efficient detection of infectious diseases across a wide range of clinical applications. As infectious diseases continue to pose significant challenges t...Read more -
From “Essential” to Action: International Day of Action for Women’s Health 2026 – Make Every Test a Promise of Health
On May 28, 2026, the world will mark the 39th International Day of Action for Women’s Health. This year’s theme rings loud and clear: “Essential, Not Optional: Strengthening Health Systems to Uphold Health Rights and SRHRJ in Times of Polycrisis.” This is no empty slogan....Read more -
Multi-Country Response to the Andes Hantavirus Cluster: NAAT and Whole-Genome Sequencing as Critical Tools
In April 2026, the Dutch-flagged polar expedition cruise ship MS Hondius departed from Ushuaia, Argentina. On 6 April, a passenger developed fever and headache, and died on board five days later. His wife also fell ill and died after being transferred to South Africa. Subsequently, a 69-year-old ...Read more -
Pharmacogenetic testing in Italy: results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy
Literature Interpretation A recent study on the implementation of pharmacogenetic (PGx) testing in Italy, published in the European Journal of Human Genetics, systematically describes the distribution of PGx testing services, technical applications, clinical implementation, regional differences, ...Read more -
Hantavirus Outbreak Update: Human-to-Human Transmission Confirmed
Outbreak Summary: A Fatal Voyage In April 2026, the Dutch flagged polar expedition cruise ship MS Hondius departed from Ushuaia, Argentina. On 6 April, a passenger developed fever and headache, dying on board five days later. His wife also fell ill and died after being transferred to South Africa...Read more -
Hantavirus Outbreak Update: Precise Detection Matters
Outbreak Summary: A Fatal Voyage In April 2026, the Dutch flagged polar expedition cruise ship MS Hondius departed from Ushuaia, Argentina. On 6 April, a passenger developed fever and headache, dying on board five days later. His wife also fell ill and died after being transferred to South Africa...Read more -
An Analysis of EGFR and ALK Detection for Precision Diagnosis and Treatment of Early-Stage NSCLC Based on the ESMO 2025 Guideline
I. Overview of the ESMO 2025 Guideline In August 2025, ESMO officially released the Early and locally advanced non small cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow up, published in the top oncology journal Annals of Oncology. This is the first comprehen...Read more -
Convite para Visitar a Macro & Micro-Test na Hospitalar 2026
Caros parceiros e profissionais da área da saúde, A Macro & Micro-Test tem o prazer de convidá-lo a visitar nosso estande na Hospitalar 2026 — o maior e mais importante evento de saúde da América Latina. -Data: 19 a 22 de maio de 2026 -Local: São Paulo Expo -Estande: F230A Há mais de uma dé...Read more -
OXA-23 Carbapenemase Detection: A Key to Antimicrobial Resistance Prevention and Control
Clinical Background Carbapenem antibiotics serve as a critical line of defense against multidrug-resistant Gram-negative bacterial infections in clinical settings. However, the diminishing efficacy of these antibiotics has become a major global public health challenge. Among the various carbapene...Read more -
CYP2C19 Genotyping at the Forefront: Interpreting the CERSI-PGx Clinical Guideline
Recently, the British Journal of Clinical Pharmacology published the first clinical guideline developed by the UK Centre of Excellence for Regulatory Science and Innovation in Pharmacogenomics (CERSI PGx), titled “CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of...Read more -
STI Awareness Week, Silent No More
-Transforming STI Screening with a Tiered Multiplex Diagnostic Portfolio in Alignment with 2025–2026 WHO Guidelines 1. The Iceberg Beneath the Surface This week, April 12–18, 2026, marks STI Awareness Week. The theme of this week serves as a powerful reminder: the global burden of sexually transm...Read more